Patents by Inventor James C. Garbe

James C. Garbe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11293008
    Abstract: A method of growing primary human epithelial cells, in particular human epithelial cells using a basal formula containing individual (a) amino acids, (b) vitamins, (c) trace elements, and (d) other organics such as linoleic acid. The basal medium may be a mixture of amino acids, vitamins, and salts that constitute the basic media that is used to culture epithelial cells over a number of population doublings, e.g., over at least one week, while maintaining a normal phenotype and exerting low stress on the cultured cells, and maintaining lineage heterogeneity.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: April 5, 2022
    Assignee: The Regents of the University of California
    Inventors: Mark A. LaBarge, Martha R. Stampfer, James C. Garbe
  • Patent number: 10870851
    Abstract: Aspects of the present disclosure include RNAs that confer a mortal phenotype and nucleic acids encoding same. Liposomes, recombinant cells, and pharmaceutical compositions that include the RNAs or nucleic acids encoding same are also provided. Further provided are methods involving quantifying MORT RNAs and/or determining the methylation status of the MORT promoter, as well as methods that employ the RNAs or nucleic acids encoding same.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: December 22, 2020
    Assignees: The Regents of the University of California, The Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: Martha R. Stampfer, James C. Garbe, Lukas Vrba, Bernard W. Futscher
  • Patent number: 10689652
    Abstract: Methods for inducing non-clonal immortalization of normal epithelial cells by directly targeting the two main senescence barriers encountered by cultured epithelial cells. In finite lifespan pre-stasis human mammary epithelial cells (HMEC), the stress-associated stasis barrier was bypassed, and in post-stasis HMEC, the replicative senescence barrier, a consequence of critically shortened telomeres, was bypassed. Early passage non-clonal immortalized lines exhibited normal karyotypes. Methods of efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation and immortalization during human carcinoma progression, methods for screening for toxic and environmental effect on progression, and the development of therapeutics targeting the process of immortalization.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: June 23, 2020
    Assignee: The Regents of the University of California
    Inventors: Martha R. Stampfer, James C. Garbe
  • Publication number: 20190352606
    Abstract: A method of growing primary human epithelial cells, in particular human epithelial cells using a basal formula containing individual (a) amino acids, (b) vitamins, (c) trace elements, and (d) other organics such as linoleic acid. The basal medium may be a mixture of amino acids, vitamins, and salts that constitute the basic media that is used to culture epithelial cells over a number of population doublings, e.g., over at least one week, while maintaining a normal phenotype and exerting low stress on the cultured cells, and maintaining lineage heterogeneity.
    Type: Application
    Filed: September 23, 2016
    Publication date: November 21, 2019
    Inventors: Mark A. LaBarge, Martha R. Stampfer, James C. Garbe
  • Publication number: 20180298382
    Abstract: Aspects of the present disclosure include RNAs that confer a mortal phenotype and nucleic acids encoding same. Liposomes, recombinant cells, and pharmaceutical compositions that include the RNAs or nucleic acids encoding same are also provided. Further provided are methods involving quantifying MORT RNAs and/or determining the methylation status of the MORT promoter, as well as methods that employ the RNAs or nucleic acids encoding same.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 18, 2018
    Inventors: Martha R. Stampfer, James C. Garbe, Lukas Vrba, Bernard W. Futscher
  • Publication number: 20170130232
    Abstract: Methods for inducing non-clonal immortalization of normal epithelial cells by directly targeting the two main senescence barriers encountered by cultured epithelial cells. In finite lifespan pre-stasis human mammary epithelial cells (HMEC), the stress-associated stasis barrier was bypassed, and in post-stasis HMEC, the replicative senescence barrier, a consequence of critically shortened telomeres, was bypassed. Early passage non-clonal immortalized lines exhibited normal karyotypes. Methods of efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation and immortalization during human carcinoma progression, methods for screening for toxic and environmental effect on progression, and the development of therapeutics targeting the process of immortalization.
    Type: Application
    Filed: September 2, 2016
    Publication date: May 11, 2017
    Applicants: The Regents of the University of California, The Arizona Board of Regents on Behalf of the University of Arizona
    Inventors: Martha R. Stampfer, James C. Garbe, Lukas Vrba, Bernard W. Futscher
  • Patent number: 9376662
    Abstract: Cell culture media formulations for culturing human epithelial cells are herein described. Also described are methods of increasing population doublings in a cell culture of finite life span human epithelial cells and prolonging the life span of human cell cultures. Using the cell culture media disclosed alone and in combination with addition to the cell culture of a compound associated with anti-stress activity achieves extended growth of pre-stasis cells and increased population doublings and life span in human epithelial cell cultures.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: June 28, 2016
    Assignee: The Regents of the University of California
    Inventors: Martha R. Stampfer, James C. Garbe
  • Publication number: 20150247121
    Abstract: Cell culture media formulations for culturing human epithelial cells are herein described. Also described are methods of increasing population doublings in a cell culture of finite life span human epithelial cells and prolonging the life span of human cell cultures. Using the cell culture media disclosed alone and in combination with addition to the cell culture of a compound associated with anti-stress activity achieves extended growth of pre-stasis cells and increased population doublings and life span in human epithelial cell cultures.
    Type: Application
    Filed: February 20, 2015
    Publication date: September 3, 2015
    Inventors: Martha R. Stampfer, James C. Garbe
  • Publication number: 20150225696
    Abstract: Methods for inducing non-clonal immortalization of normal epithelial cells by directly targeting the two main senescence barriers encountered by cultured epithelial cells. In human mammary epithelial cells (HMEC), the stress-associated stasis barrier was bypassed and the replicative senescence barrier, a consequence of critically shortened telomeres, was bypassed in post-stasis HMEC. Early passage non-clonal immortalized lines exhibited normal karyotypes. Methods of efficient HMEC immortalization, in the absence of “passenger” genomic errors, should facilitate examination of telomerase regulation, immortalization during human carcinoma progression, and methods for screening for toxic and environmental effect on progression.
    Type: Application
    Filed: October 2, 2014
    Publication date: August 13, 2015
    Applicants: The Regents of the University of California, THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
    Inventors: Martha R. Stampfer, James C. Garbe, Lukas Vrba, Bernard W. Futscher
  • Patent number: 8962325
    Abstract: Cell culture media formulations for culturing human epithelial cells are herein described. Also described are methods of increasing population doublings in a cell culture of finite life span human epithelial cells and prolonging the life span of human cell cultures. Using the cell culture media disclosed alone and in combination with addition to the cell culture of a compound associated with anti-stress activity achieves extended growth of pre-stasis cells and increased population doublings and life span in human epithelial cell cultures.
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: February 24, 2015
    Assignee: The Regents of the University of California
    Inventors: Martha R. Stampfer, James C. Garbe
  • Publication number: 20100022000
    Abstract: Cell culture media formulations for culturing human epithelial cells are herein described. Also described are methods of increasing population doublings in a cell culture of finite life span human epithelial cells and prolonging the life span of human cell cultures. Using the cell culture media disclosed alone and in combination with addition to the cell culture of a compound associated with anti-stress activity achieves extended growth of pre-stasis cells and increased population doublings and life span in human epithelial cell cultures.
    Type: Application
    Filed: September 30, 2008
    Publication date: January 28, 2010
    Applicant: The Regents of the University of California
    Inventors: Martha R. Stampfer, James C. Garbe